Production of CAR T-cells by GMP-grade lentiviral vectors: Latest advances and future prospects

AbstractChimeric antigen receptor (CAR) T-cells represent a paradigm shift in cancer immunotherapy and a new milestone in the history of oncology. In 2017, the Food and Drug Administration approved...